Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers

: Laura Heinonen, Birgitta Sandberg

Publisher: Springer

: 2008

: Journal of Commercial Biotechnology

: 14

: 287

: 298

: 12

: https://link.springer.com/article/10.1057/jcb.2008.25